The official blog of the Lung Institute.

Lung Institute Celebrates 3 Years of Helping Lung Disease Patients with Cellular Treatment Therapy

3 May 2016
| Under Featured, Press | Posted by

To celebrate its three-year anniversary on May 14th, the Lung Institute will give away a free treatment at several clinic locations across the United States.

TAMPA, Fla. The Lung Institute will celebrate its three-year anniversary on May 14 by giving away a free treatment* to one person attending a seminar at most clinic locations throughout the month of May. To date, the Lung Institute has treated over 2,000 people at their five clinics across the country.

Sign up for each seminar here: 

May 5 – Nashville, TN
May 7 – Dallas, TX
May 10 – Scottsdale, AZ
May 17 – Tampa, FL
May 24 – Pittsburgh, PA

“The rapid growth that we’ve seen is a testament to the success of this treatment and to the patients who refuse to give up,” says Lung Institute doctor Jack Coleman, Jr., M.D. “We admire our patients’ strength and determination, and developed the Your Strength Gives Hope campaign to highlight the successes they’ve experienced in their own lives since receiving cellular therapy at one of our clinics.”

The Lung Institute developed the Your Strength Gives Hope campaign to recognize the patients who believed in the treatment from the start. In a society that’s fixated on youth, the indignities of aging can be hard to accept. For those who suffer from a chronic disease, the challenges of growing older can seem unbearable. Living with a chronic lung disease like chronic obstructive pulmonary disease (COPD), the third leading cause of death in the United States, presents a host of significant challenges.

There are four stages of COPD. While patients in stage one might not even know they have the disease, people with stages three and four will experience a severe reduction in their quality of life. People experiencing the latter stages of COPD may lack the endurance to take a shower without sitting down or the strength for a trip to the mailbox. Depression can go hand in hand with COPD, since the disease hinders a person’s ability to fully enjoy life.

The Lung Institute seeks to alleviate the challenges faced by people who suffer from chronic lung disease by helping them breathe more easily. A recent white paper summarizing the experience of 100 patients reveals that 82 percent of patients report an improved quality of life after treatment. “Quality of life” means different things for different people. For some, it can mean the ability to take out the garbage or do yard work. For others, it’s a walk around the block or playing golf with friends. In some cases, patients can reduce or eliminate the burden of relying on supplemental oxygen. Regardless of what a better quality of life means to each person, patients are thrilled to reclaim some part of themselves previously stolen by illness.

“I am no longer on oxygen and I can walk for a longer period of time than before the treatment.”

Charlotte B. | Age: 64 | Location: Vineland, NJ

“We couldn’t be more thankful for our patients’ strength, the Lung Institute clinical staff and this treatment that is truly changing lives,” says Dr. Coleman. “The three-year anniversary marks a great accomplishment in the fight against lung disease, and we look forward to continuing to improve lives.”

About the Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and interstitial lung disease in the United States. To date, the organization has treated over 2,000 patients, 82 percent of whom report an improved quality of life. Founded in 2013 in Tampa, Fla., the Lung Institute currently operates clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 382-8095.


*A free treatment will be given away at every clinic except Dallas.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.